Literature DB >> 2382798

Serum sickness-like syndrome associated with minocycline therapy.

J Puyana1, V Ureña, S Quirce, M Fernandez-Rivas, M Cuevas, J Fraj.   

Abstract

A 19 year-old youth was taking oral minocycline and after 8 days he presented all four cardinal symptoms of serum sickness (urticaria, fever, lymphadenopathy and joint symptoms). C3, C4 and CH50 evolution imitate experimental serum sickness complement evolution. We exclude other causes of this syndrome. Although other hypersensitivity reactions have occurred with minocycline usage, to our knowledge serum sickness-like syndrome has not been previously reported with this drug.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2382798     DOI: 10.1111/j.1398-9995.1990.tb00502.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  7 in total

Review 1.  Benefits and risks of minocycline in rheumatoid arthritis.

Authors:  P Langevitz; A Livneh; I Bank; M Pras
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA.

Authors:  O Elkayam; M Yaron; D Caspi
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

Review 3.  Drug-induced severe skin reactions. Incidence, management and prevention.

Authors:  P Wolkenstein; J Revuz
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

4.  Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome.

Authors:  A Gough; S Chapman; K Wagstaff; P Emery; E Elias
Journal:  BMJ       Date:  1996-01-20

5.  Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes.

Authors:  Karen Frankwich; Courtney Tibble; Moises Torres-Gonzalez; Mariah Bonner; Roy Lefkowitz; Matt Tyndall; Geert W Schmid-Schönbein; Francisco Villarreal; Mike Heller; Karen Herbst
Journal:  J Inflamm (Lond)       Date:  2012-10-01       Impact factor: 4.981

Review 6.  Allergic emergencies encountered by the dermatologist. Severe cutaneous adverse drug reactions.

Authors:  P Wolkenstein; J Revuz
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 10.817

Review 7.  A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea.

Authors:  Ana M Martins; Joana M Marto; Jodi L Johnson; Emmy M Graber
Journal:  Antibiotics (Basel)       Date:  2021-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.